BHVNSMALL

Biohaven Ltd.

HealthcareBiotechnology
$10.04
$0.00(+3.40%)
52W$7.48
$22.05
Updated May 7, 12:00 AM
RSI49
RS Rating15/99
Beta1.35
Volatility90%
F-Score2/9
Mkt Cap$1.1B
WEAKENING

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

WEAKENING

Biohaven Ltd. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 15), showing significant lag compared to the market leaders. Earnings growth of 59% provides fundamental context to the price action. Investors should exercise caution due to high volatility (90% annualized), which requires wider risk management.

Relative Strength
15
out of 99
Lagging
Trend Score
1/4
Minervini Criteria
WEAKENING
Risk (Beta)
1.35
vs S&P 500
ABOVE MKT
52W Position
18%
from 52W low
Near Low
Trend & Momentum Analysis

Trend Template (Minervini)

WEAKENING1/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$9.82
50 SMA > 100 SMA$10.71
100 SMA > 150 SMA$11.38
150 SMA > 200 SMA$12.20

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$10.00+0.36%ABOVE
50 SMA$9.82+2.25%ABOVE
100 SMA$10.71-6.23%BELOW
150 SMA$11.38-11.80%BELOW
200 SMA$12.20-17.73%BELOW

Price Performance

1D+3.4%
1W+9.1%
1M+9.7%
3M-13.4%
6M+17.7%
YTD-7.4%
1Y-47.6%
3Y-10.9%
52-Week Trading Range18% from low
$10.04
52W Low$7.48
52W High$22.05

Technical Indicators

RSI (14)NEUTRAL
48.5
305070
VCP ScoreCOOL
3/10
Base depth: 50.3%

Risk Profile

Beta
1.35
52W Vol
90%
ATR
$0.66
Max DD (1Y)
-66%

Volume Analysis

Today
2.03M
50D Avg
2.04M
Vol Ratio
0.99x
Liquidity
MODERATE

Earnings Momentum

Q2'25+47%
$-1.94
Q3'25+4%
$-1.64
Q4'25+35%
$-1.21
Q1'26+59%
$-0.88
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:
5 Years:
3 Years:
TTM:

Compounded Profit Growth

10 Years:
5 Years:
3 Years:
TTM:+39.42%

Stock Price CAGR

10 Years:+3.24%
5 Years:+6.58%
3 Years:-10.93%
1 Year:-47.63%

Return on Equity

10Y Avg:-227.6%
5Y Avg:-204.7%
3Y Avg:-198.0%
Last Year:-866.5%

Key Metrics

Market Cap$1.1B
Gross Margin
Net Margin
Piotroski F-Score2/9

Frequently Asked Questions

Is BHVN in an uptrend right now?

BHVN has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.

Is BHVN overbought or oversold?

BHVN's RSI (14) is 49. The stock is in neutral territory, neither overbought nor oversold.

Is BHVN outperforming the market?

BHVN has a Relative Strength (RS) Rating of 15 out of 99. BHVN is currently lagging the broader market.

Where is BHVN in its 52-week range?

BHVN is trading at $10.04, which is 46% of its 52-week high ($22.05) and 18% above its 52-week low ($7.48).

How volatile is BHVN?

BHVN has a Beta of 1.35 and 52-week volatility of 90%. It's more volatile than the S&P 500 - expect bigger swings.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.